  | | | | | PARIS (Reuters) - Stocks and safe-haven government bonds in Europe edged higher on Wednesday, with the prospect of more monetary stimulus from the European Central Bank offsetting a drop in German business sentiment. | | |  | | | | | NEW YORK (Reuters) - Merrimack Pharmaceuticals shares were surging in premarket trade, up 24.5 percent to $8.95 after the company said it reached a deal to develop and market Merrimack's pancreatic cancer drug outside the U.S. with Baxter International. | | | |  | | | | | (Reuters) - U.S. regulator the Securities and Exchange Commission is investigating whether bond fund manager Pimco inflated the returns of its Total Return Exchange-Traded Fund run by founder Bill Gross, who has come under renewed fire from investors this year over the poor performance of his main fund. | | | |  | | | | | (Reuters) - Consulting and outsourcing company Accenture Plc forecast first-quarter revenue largely below analysts' expectations as stiff competition from rivals hurt new contracts wins. | | | |  | | | | | SAN FRANCISCO (Reuters) - Amazon.com Inc will boost staffing at its secretive Silicon Valley-based hardware unit by at least 27 percent over the next five years as it tests Internet-connected "smart" home gadgets such as a one-button device to order supplies. | | | |  | | | | | WOLFSBURG Germany (Reuters) - In an era of automation, robotics and spotless factory floors, you don't expect to see car workers lugging metal along a production line. | | | |  | | | | | LONDON(Reuters) - The biggest U.S. bank listing since the financial crisis got a lukewarm reception from investors, forcing Royal Bank of Scotland RBS.L to cut the price of shares sold in Citizens Financial Group CFG.N. | | | |  | | | | | ISTANBUL (Reuters) - Aircraft leasing companies voiced confidence in steady jetliner demand, but warned new aviation investors that they may take a painful hit when central banks start unwinding their efforts to stimulate the economy. | | |  | | | | | NEW YORK (Reuters) - U.S. drugstore chain operator Walgreen Co is exploring the sale of a majority stake in its infusion services business, in a deal that could value that division at around $1.5 billion, according to four people familiar with the matter. | | |  | | | | | SYDNEY/HONG KONG (Reuters) - National Australia Bank (NAB) is considering the sale of its life insurance unit worth an estimated $800 million, seeking to boost earnings and returns on capital, people familiar with the matter told Reuters. | | | |  |  | | | A daily digest of breaking business news, coverage of the US economy, major corporate news and the financial markets. Register Today | | |  | |  | | | The latest Reuters articles on M&A, IPOs, private equity, hedge funds and regulatory updates delivered to your inbox each day. Register Today | | | | | | » MORE NEWSLETTERS | |
No comments:
Post a Comment